Apocynin ameliorates liver fibrosis events in vivo through modulation of oxidative stress, inflammatory, and apoptotic mediators

dc.contributor.authorAhmed, Khaled Abdul-aziz
dc.contributor.authorAlqaisi, Khalid M.
dc.contributor.authorIbrahim, Noralhuda Ayad
dc.contributor.authorAl-Qaisi, Talal Salem
dc.contributor.authorE.T.A.L..
dc.date.accessioned2026-01-12T05:46:50Z
dc.date.available2026-01-12T05:46:50Z
dc.date.issued2025
dc.descriptionLiver fibrosis (LF) is a chronic health disorder that occurs in progressive phases of all chronic liver diseases, characterized by tissue fibrosis, necrosis, and numerous regenerative hepatic nodules.
dc.description.abstractThe liver has a tremendous regeneration potential, yet chronic liver injury poses a life-threatening condition if not managed appropriately. Apocynin, an NADPH oxidase inhibitor, has been a central focus of attention in recent years due to its significant antioxidant/anti-inflammatory potentials. In this study, we evaluated the acute toxicity and hepatoprotective effects of Apocynin against thioacetamide (TAA)-induced liver fibrosis in rats. Liver fibrosis was induced by 200 mg/kg TAA three times/week for two months, along with treatment with distilled water (positive control), silymarin (reference, 50 mg/kg), or apocynin (50 and 100 mg/kg/day). Hepatic tissues were screened for histopathological, biochemical, and immunohistochemical changes, while hepatic homogenate was examined for the antioxidant contents (catalase, CAT; superoxide dismutase, SOD) and MDA levels. Apocynin treatment showed significant hepatoprotective effects against TAA-hepatotoxicity, evidenced by reduced hepatic tissue alterations with a slight fibroplasia, reduction of hepatomegaly, less hepatic nodules/necrosis, and recovered hepatic function. Additionally, apocynin administration reduced oxidative stress by lowering pro-oxidants (MDA) and up-regulating antioxidants (SOD and CAT). Furthermore, the anti-apoptotic and anti-fibrotic effects of apocynin were confirmed by reduced pro-apoptotic P53 proteins and β-catenin (tissue proliferation/aggregation enhancer). Apocynin treatment ameliorated ECM generation (lowered collagen bundles/fibrous septa) and reduced inflammatory (less TNf-α and IL-6 cytokines) mediators, all of which restored liver functional parameters (ALT, AST, ALP, and albumin). Apocynin attenuated TAA-mediated liver fibrosis by its modulatory potentials on several cytoprotective mechanisms associated with the oxidative stress/inflammation, making it a viable therapeutic source for liver fibrosis. Keywords: Apocynin, Liver Fibrosis, Thioacetamide, Antioxidants, Histopathology
dc.identifier.citationAhmed, K. A. A., Alqaisi, K. M., Ibrahim, N. A., Abdullah, S. S., Jabbar, A. A., Saleh, G. N., ... & Althagbi, H. I. (2025). Apocynin ameliorates liver fibrosis events in vivo through modulation of oxidative stress, inflammatory, and apoptotic mediators. BMC Pharmacology and Toxicology, 26(1), 207.
dc.identifier.doihttps://doi.org/10.1186/s40360-025-01041-8
dc.identifier.urihttps://repository.adu.ac.ae/handle/1/7928
dc.language.isoen
dc.publisherSpringer Nature
dc.titleApocynin ameliorates liver fibrosis events in vivo through modulation of oxidative stress, inflammatory, and apoptotic mediators
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Apocynin ameliorates liver fibrosis.pdf
Size:
4.6 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: